Breo Ellipta Lawsuit: $89.7M Patent Verdict, Generic Disputes, and Antitrust Claims
The Breo Ellipta lawsuit draws strong public interest. Breo Ellipta is a prescription inhaler that contains fluticasone furoate and vilanterol. Doctors prescribe it to treat asthma and chronic obstructive pulmonary disease. Several legal disputes now connect to this medication. A major patent infringement case resulted in an $89.7 million verdict against GlaxoSmithKline. Separate lawsuits raise…










